Pregabalin Capsule
Product Images NDC 70518-2762

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 70518-2762). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Pregabalin is a medication that comes in 50 mg capsules manufactured by Novadoz Pharmaceuticals LLC. It comes in a package of 90 capsules and requires a prescription. The medication should be kept out of the reach of children and should be stored at a temperature of 20-26°C. The lot number and expiration date are not available in the provided text. The directions for use can be found in the package insert. This medication has been repackaged by RemedyRepack Inc. in Indiana, PA.*

FDA Label Image

Equation (Pregabain Gault Equation)

This formula is used to calculate the creatinine clearance rate (CLCr) which is a measure of kidney function. It takes into account the patient's age, weight, and serum creatinine level. The formula differs slightly for female patients who have a multiplying factor of 0.85.*

FDA Label Image

Fig-01 (Pregabalin Figure 01)

This text presents the percentage of patients who improved with different doses of Pregabalin (25mg, 100mg and 200mg taken three times a day) compared to a placebo. The data also shows the percentage of pain improvement from the baseline for each treatment.*

FDA Label Image

Fig-02 (Pregabalin Figure 02)

The text is describing the percentage of patients who improved in relation to pain management with Pregabalin 100 mg three times a day and Placebo. The data is presented graphically with a chart which shows the percentage of improvement in pain from baseline on the horizontal axis and the percentage of patients improved on the vertical axis.*

FDA Label Image

Fig-03 (Pregabalin Figure 03)

FDA Label Image

Fig-04 (Pregabalin Figure 04)

This is a graph that shows the results of a study on the effectiveness of Pregabalin in pain management. The x-axis shows the percent improvement in pain from baseline, while the y-axis shows the percentage of patients who showed improvement. The graph shows that a higher percentage of patients improved with Pregabalin (at both 100mg and 200mg doses) than with placebo.*

FDA Label Image

Fig-05 (Pregabalin Figure 05)

The text represents a chart showing the percentage of patients who improved based on the medication they were given, with pregabalin 100mg three times a day showing the highest improvement percentage at over 60%. The chart also includes percent improvement in pain from baseline.*

FDA Label Image

Fig-06 (Pregabalin Figure 06)

FDA Label Image

Fig-07 (Pregabalin Figure 07)

FDA Label Image

Fig-09 (Pregabalin Figure 09)

This appears to be a chart showing the percentage of patients who experienced improvement in pain from baseline while taking different doses of pregabalin or placebo. The chart also includes the percentage of improvement in pain for each dose category.*

FDA Label Image

Fig-10 (Pregabalin Figure 10)

FDA Label Image

Fig-11 (Pregabalin Figure 11)

The text describes a graph showing the percentage of subjects who improved over 12 weeks after taking pregabalin compared to a placebo. The graph shows a scale from 0 to 100 on the x-axis and the percent of subjects improved on the y-axis. There is also a key indicating that the blue line represents pregabalin, and the gray line represents the placebo.*

FDA Label Image

Fig-12 (Pregabalin Figure 12)

This is a chart showing the percent improvement of subjects taking Pregabalin compared to Placebo from Baseline to Week 16. The percentage of improvement ranges from 10 to 80 with both Pregabalin and Placebo showing improvement. The chart also includes a column for percent of subjects improved, with the highest percentage being 100.*

FDA Label Image

Str (Pregabalin Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.